NL-OMON51405
Not yet recruiting
Not Applicable
The role of gutmicrobiota composition, epigenetics and autoimmunity in the development and treatment of vasculitis; the VASKIR biobank - GAVAS
Amsterdam UMC0 sites500 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- vasculitis
- Sponsor
- Amsterdam UMC
- Enrollment
- 500
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •All individuals with vasculitis visiting the outpatient clinic of Amsterdam
- •UMC region are potentially eligible if they are \>18 years old
- •Vasculitis diagnosis is made by clinician. Vasculitis subtype will be
- •recorded along with the presence of auto\-antibodies at time of diagnosis and
- •during remission (where applicable, e.g., in the case of AAV)
Exclusion Criteria
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •Active infection at the time of inclusion (not to influence immune\-cell
- •Unwillingness to donate feces, urine and/or blood
- •Inability to provide informed consent based on cognitive function, language
- •barrier or other reasons
- •Absence of large bowel (i.e., colostomy)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The role of intestinal microbiota composition and intestinal permeability in the development of (complicated) diverticular disease.Outpocketings of colonic mucosa10013535NL-OMON35377Medisch Universitair Ziekenhuis Maastricht210
Recruiting
Not Applicable
Exploring the modulatory effects of gut microbiota on cholangiocarcinoma progression in a patient-derived organoid modelCholangiocarcinomaC22.1Intrahepatic bile duct carcinomaDRKS00033188nimedizin Mainz, Klinik für Allgemein-, Viszeral- und Transplantationschirurgie20
Not yet recruiting
Not Applicable
The role of the gut microbiome in the pathogenesis of IgA nephropathyNL-OMON49937Radboud Universitair Medisch Centrum150
Active, not recruiting
Phase 1
Gut microbiota, PGx and INSTIs responseEUCTR2020-001103-17-BECliniques universitaires Saint-Luc200
Completed
Early Phase 1
Epigenetic and Microbiota ModificationsDiabetes type2ObesityNCT05076656Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud22